Lo Coco 2019


Group Treatment for Substance Use Disorder in Adults: Systematic Review and Meta-Analysis of Randomized-Controlled Trials

Authors: Gianluca Lo Coco, Francesco Melchiori, Veronica Oieni, Maria Rita Infurna, Bernhard Strauss, Dominique Schwartze, Jenny Rosendahl, Salvatore Gullo
Institutions: Multiple universities including University of Palermo, University Niccolò Cusano, University Hospital Jena
Journal: Journal of Substance Abuse Treatment
Keywords: Group psychotherapy, Substance use disorder (SUD), Abstinence, Systematic review, Meta-analysis


1. Abstract

  • Background and Aims: Group therapy is prevalent in addressing substance misuse across various treatment settings, despite the lack of a systematic review of its effectiveness. This meta-analysis evaluates the efficacy of group therapy for SUDs in adults.

  • Methods: Studies comparing group psychotherapy to no treatment, individual psychotherapy, medication, self-help groups, or other treatments (not using specific psychotherapeutic techniques) were included. Primary outcome was abstinence; secondary outcomes included frequency of substance use, SUD symptoms, anxiety, depression, general psychopathology, and treatment attrition.

  • Results: 33 studies were included. Small significant effects of group therapy were noted on abstinence compared to no treatment, individual therapy, and other treatments. No significant effects were found for substance use frequency or SUD symptoms, but mental state showed moderate effects versus no treatment.

  • Conclusions: This meta-analysis provides an important overview of group therapy's role in treating adult SUDs, although results warrant cautious interpretation due to data limitations.


2. Introduction

  • Context: Substance use affects a significant part of the global population. The World Health Organization estimates a worldwide burden of 5.4% of disease associated with drug and alcohol issues.

    • USA Data: In 2014, 21.5 million Americans aged 12 and up faced SUD (Center for Behavioral Health Statistics and Quality, 2015).

  • Definition of SUD: As per DSM-5, SUD is characterized by cognitive, behavioral, and physiological patterns indicating continued use despite significant issues.

  • Comorbidity: High rates (30%-45%) of psychiatric comorbidity among individuals with SUD; complicating treatment (Broome et al., 1999).

  • Efficacy of Psychosocial Interventions: Various interventions (e.g., coping skills training, relapse prevention) have shown effectiveness in treating SUD (Carroll & Onken, 2005).

  • Group Therapy Popularity: Increasing acceptance due to clinical reasons (social support, influence on behavior, etc.) and cost efficiency (Spitz, 2001).

  • Literature Review Gap: Previous studies demonstrated positive outcomes for group therapy, but less remain published about its efficacy compared to individual therapy and controls, especially in well-defined RCTs.


3. Methods

3.1. Protocol and Registration
  • Study Basis: Part of a project summarizing group psychotherapy evidence across mental disorders (PROSPERO registration CRD42013004419).

3.2. Eligibility Criteria
  • Inclusion Criteria: Randomized-controlled trials published post-1990 targeting adults with SUD as the primary diagnosis (DSM or ICD). No restrictions on comorbidity.

  • Interventions: Group treatments with at least 3 patients and one therapist conducting a minimum of 5 sessions. Compared to any control groups, inclusive of medications or self-help therapy.

  • Assessment: Primary outcome was abstinence; secondary outcomes measured various psychological symptoms and attrition rates.

3.3. Information Sources and Search Methods
  • Electronic Search: Conducted in Medline, Web of Science, CENTRAL, and PsycInfo with a manual search of reference lists.

3.4. Study Selection Process
  • Selection Procedure: Reviews performed in pairs to determine eligibility; disagreements resolved through discussion.

3.5. Data Collection
  • Data Extraction: Key data fields included patient demographics, intervention specifics, comparators, outcomes, and statistical parameters. Effects sizes per study were extracted carefully.

3.6. Risk of Bias in Individual Studies
  • Assessment: Cochrane Risk of Bias Tool employed for internal validity, assessing elements like selection bias and reporting bias.

3.7. Summary Measures
  • Effect Sizes Calculation: Between-group effect sizes computed with 95% confidence intervals. Hedges' g was used for continuous variables while relative risks were computed for dichotomous outcomes.

3.8. Analysis Details
  • Random Effects Models: Employed to aggregate effect sizes; heterogeneity quantified using Q-statistics and I² (% of variance in effects).

3.9. Risk of Bias Assessment Across Studies
  • Funnel Plots & Egger's Test: Used for assessing publication bias, indicating no significant evidence against primary outcomes.

3.10. Additional Analyses
  • Sensitivity Analyses: Conducted to confirm findings, assessing results among different risk categories of studies.


4. Results

4.1. Study Selection Outcomes
  • Records Identified: 7873 from database searches; 31 primary studies and 2 follow-up publications met inclusion criteria.

4.2. Study Characteristics
  • Diverse Population: Various substances were studied, including alcohol, cocaine, heroin, cannabis, etc.

  • Demographics: Median age 38; 36.2% female. Majority had comorbid disorders (e.g., depression).

4.3. Summary of Biases
  • Most studies were rated for low risk of bias in random allocation (13 low, 2 high).

4.4. Result Analysis
  • Primary Outcomes: Significant small effects of group therapy on abstinence; clear results for no treatment comparisons but mixed for individual vs. other treatments.

    • Frequency of Substance Use and SUD Symptoms: Non-significant results detected across group comparisons.

4.5. Follow-Up Results
  • Longer-term follow-up indicated increased abstinence rates compared to other treatments.


5. Discussion

  • Efficacy of Group Therapy: Although positive short-term effects on abstinence were noted, overall effects were small. Study heterogeneity noted, particularly among varied treatment types.

  • Long-Term Efficacy Indications: Modest improvements were observed; however, many studies need follow-up assessments for conclusive implications.

  • Attrition Concerns: High dropout rates indicate potential difficulties in maintaining treatment engagement among SUD patients.


6. Limitations and Future Directions

  • Variable Study Quality: Issues with self-reports, limited treatment types, and demographic representation can skew results.

  • Broader Implications: More research is warranted on varying treatment approaches, especially for individuals with dual diagnoses.


7. Conclusion

  • Integration of Research Findings: Group treatment shows promise in promoting abstinence for adults with SUDs, yet more comprehensive studies are necessary to determine its effectiveness across diverse populations.